17 March 2021

At the meeting of 16 February 2021 the RMA:

Determined Statements of Principles (SOPs) for:

Condition SOPs
asthma 31/2021 32/2021
acute lymphoblastic leukaemia/lymphoblastic lymphoma 33/2021 34/2021
deep vein thrombosis 35/2021 36/2021
pulmonary thromboembolism 37/2021 38/2021

Note: 

  • The investigation concerning 'acute lymphoblastic leukaemia' has resulted in the determination of Statements of Principles concerning acute lymphoblastic leukaemia/lymphoblastic lymphoma.

The above SOPs take effect from 5 April 2021.

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
porphyria cutanea tarda Intention to remove one or more factors May 2021
malignant neoplasm of the oral cavity, oropharynx and hypopharynx Intention to remove one or more factors May 2021
pes planus Intention to remove one or more factors May 2021
IgA nephropathy Intention to remove one or more factors May 2021

Completed Investigations

The above determinations conclude the previously advertised investigations into:

New Investigations

Decided to advertise the following investigations:

The above investigation notices appear in the Government Notices Gazette of 9 March 2021.